CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


0.5% Povidone/Iodine oral/nasal rinseWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (6)


Name (Synonyms) Correlation
drug4 0.12% Chlorhexidine oral/nasal rinse Wiki 1.00
drug2181 Saline oral/nasal rinse Wiki 1.00
drug89 ATV Wiki 1.00
drug307 BR Wiki 1.00
drug705 DRV Wiki 1.00
drug594 Cobicistat Wiki 1.00

Correlated MeSH Terms (3)


Name (Synonyms) Correlation
D000163 Acquired Immunodeficiency Syndrome NIH 0.58
D015658 HIV Infections NIH 0.41
D007153 Immunologic Deficiency Syndromes NIH 0.41

Correlated HPO Terms (1)


Name (Synonyms) Correlation
HP:0002721 Immunodeficiency HPO 0.41

There is one clinical trial.

Clinical Trials


1 A Phase II, Randomized, Open-label, Single-institution Study of the Effects of Povidone Iodine Oral Gargles and Nasal Rinses on Viral Load in Patients With COVID-19

For this study, 48 patients who have been diagnosed with COVID-19 will be randomly assigned to four study groups: control, saline, chlorhexidine gluconate, and povidone-iodine. Each patient will be asked to gargle with a solution of either saline, chlorhexidine gluconate, or povidone-iodine or nothing (control group) as well as spray the same solution in their nose four times daily. Patients will then be tested for COVID-19 once daily in the evening for 7 days and viral loads will be measured.

NCT04344236 COVID-19 Drug: Saline oral/nasal rinse Drug: 0.5% Povidone/Iodine oral/nasal rinse Drug: 0.12% Chlorhexidine oral/nasal rinse

Primary Outcomes

Description: nasopharyngeal swab for viral PCR will be taken at the end of each day for 7 days

Measure: Viral load (and/or cycle time to PCR as a proxy for quantitative viral load) in the nasopharynx and oropharynx

Time: 7 days

Secondary Outcomes

Description: Recorded daily

Measure: Oxygen requirement of the patient

Time: 7 days

Description: Recorded daily

Measure: Oxygen saturation of the patient

Time: 7 days


No related HPO nodes (Using clinical trials)